Vincristine and Temozolomide in Combination With PEN-866 for Adolescents and Young Adults With Relapsed or Refractory Solid Tumors
Clinical trial NCT04890093 · SUSPENDED
Trial details
- NCT number
- NCT04890093
- Sponsor
- National Cancer Institute (NCI)
- Status
- SUSPENDED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-10-31
- Primary completion
- 2026-12-31
- Enrollment
- 64
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.